A detailed history of Gilder Gagnon Howe & CO LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 1,230,891 shares of BSX stock, worth $109 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares
1,230,891
Previous 1,128,740 9.05%
Holding current value
$109 Million
Previous $86.9 Million 18.66%
% of portfolio
1.31%
Previous 1.15%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $7.45 Million - $8.58 Million
102,151 Added 9.05%
1,230,891 $103 Million
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $76 Million - $87.7 Million
1,128,740 New
1,128,740 $86.9 Million
Q4 2021

Feb 14, 2022

SELL
$38.07 - $44.87 $785,917 - $926,296
-20,644 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$41.23 - $45.88 $123 - $137
-3 Reduced 0.01%
20,644 $896,000
Q2 2021

Aug 16, 2021

SELL
$38.58 - $44.24 $3,896 - $4,468
-101 Reduced 0.49%
20,647 $883,000
Q1 2021

May 17, 2021

SELL
$35.27 - $39.67 $1,058 - $1,190
-30 Reduced 0.14%
20,748 $802,000
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $15,978 - $20,229
-482 Reduced 2.27%
20,778 $747,000
Q3 2020

Nov 16, 2020

SELL
$34.44 - $42.23 $31,443 - $38,555
-913 Reduced 4.12%
21,260 $812,000
Q2 2020

Aug 14, 2020

SELL
$30.19 - $39.11 $25,842 - $33,478
-856 Reduced 3.72%
22,173 $778,000
Q1 2020

May 15, 2020

SELL
$25.83 - $45.71 $480,153 - $849,703
-18,589 Reduced 44.67%
23,029 $751,000
Q3 2019

Nov 14, 2019

SELL
$40.31 - $43.45 $20,235 - $21,811
-502 Reduced 1.19%
41,618 $1.69 Million
Q2 2019

Aug 13, 2019

BUY
$34.91 - $42.98 $9,041 - $11,131
259 Added 0.62%
42,120 $1.81 Million
Q1 2019

May 17, 2019

SELL
$32.91 - $40.75 $23,201 - $28,728
-705 Reduced 1.66%
41,861 $1.61 Million
Q4 2018

Feb 14, 2019

SELL
$31.73 - $39.04 $2,950 - $3,630
-93 Reduced 0.22%
42,566 $1.5 Million
Q3 2018

Oct 30, 2018

SELL
$32.83 - $38.63 $17,925 - $21,091
-546 Reduced 1.26%
42,659 $1.64 Million
Q2 2018

Jul 31, 2018

SELL
$26.84 - $34.32 $4,133 - $5,285
-154 Reduced 0.36%
43,205 $1.41 Million
Q1 2018

Apr 30, 2018

SELL
$25.2 - $28.54 $24,721 - $27,997
-981 Reduced 2.21%
43,359 $1.19 Million
Q4 2017

Jan 31, 2018

SELL
$24.79 - $29.8 $41,052 - $49,348
-1,656 Reduced 3.6%
44,340 $1.1 Million
Q3 2017

Nov 06, 2017

BUY
$26.26 - $29.17 $1.21 Million - $1.34 Million
45,996
45,996 $1.34 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $127B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.